David Chang

Track

Insider profile

Currently holds positions in Kite Pharma Inc and Allogene Therapeutics Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Research and Development, Chief Medical Officer Kite Pharma Inc June 1, 2014 -
President, Chief Executive Officer, Co-Founder, Director Allogene Therapeutics Inc June 1, 2018 -
David Chang's trades of Allogene Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
133.25
Quantity 44,130
Value US$4,777,602
Transaction date
Proposed sale
Price
1.80
Quantity 243,976
Value US$438,522
Transaction date
Proposed sale
Price
1.96
Quantity 46,668
Value US$91,469
Transaction date
Proposed sale
Price
1.68
Quantity 46,003
Value US$77,446
Transaction date
Proposed sale
Price
4.33
Quantity 53,393
Value US$231,065
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-18 2026-03-16
S Sale
1,656 +35.2%
327.98
US$3,405,242 		1,656 +35.2% 327.98 US$3,405,242
2026-03-16 2026-03-16
PrS Proposed sale
44,130
133.25
US$4,777,602 		44,130 133.25 US$4,777,602
2026-02-04 2026-02-02
S Sale
91,535 +43.7%
289.19
US$2,861,107 		91,535 +43.7% 289.19 US$2,861,107
2026-02-02 2026-02-02
PrS Proposed sale
243,976
1.80
US$438,522 		243,976 1.80 US$438,522
2025-03-18 2025-03-14
S Sale
46,668 -0.9%
1.96
US$91,469 		46,668 -0.9% 1.96 US$91,469
2025-03-14 2025-03-14
PrS Proposed sale
46,668
1.96
US$91,469 		46,668 1.96 US$91,469
2025-02-05 2025-02-03
S Sale
46,003 -0.9%
1.68
US$77,285 		46,003 -0.9% 1.68 US$77,285
2025-02-03 2025-02-03
PrS Proposed sale
46,003
1.68
US$77,446 		46,003 1.68 US$77,446
2024-03-14 2024-03-14
PrS Proposed sale
53,393
4.33
US$231,065 		53,393 4.33 US$231,065
2022-03-17 2022-03-15
S Sale
23,648 -1.0%
7.65
US$180,879 		23,648 -1.0% 7.65 US$180,879
2021-03-17 2021-03-15
S Sale
20,513 -0.9%
38.57
US$791,271 		20,513 -0.9% 38.57 US$791,271
2020-03-18 2020-03-16
S Sale
1,625 -0.1%
20.06
US$32,603 		1,625 -0.1% 20.06 US$32,603
2020-03-18 2020-03-16
S Sale
18,710 -0.8%
19.24
US$360,012 		18,710 -0.8% 19.24 US$360,012